- Home
- YSXT vs PLUR Comparison
YSXT vs PLUR Comparison
Compare YSXT & PLUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | YSXT | PLUR |
|---|---|---|
| Founded | 2011 | 2001 |
| Country | China | Israel |
| Employees | N/A | N/A |
| Industry | Automotive Aftermarket | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.5M | 28.4M |
| IPO Year | 2024 | N/A |
Fundamental Metrics
Financial Performance| Metric | YSXT | PLUR |
|---|---|---|
| Price | $1.38 | $3.09 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | ★ 714.1K | 20.6K |
| Earning Date | 02-15-2026 | 02-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.18 | N/A |
| Revenue | ★ $71,452,736.00 | $1,326,000.00 |
| Revenue This Year | N/A | $97.38 |
| Revenue Next Year | N/A | $293.97 |
| P/E Ratio | $7.66 | ★ N/A |
| Revenue Growth | 22.04 | ★ 121.74 |
| 52 Week Low | $1.13 | $2.82 |
| 52 Week High | $9.96 | $7.13 |
Technical Indicators
Market Signals| Indicator | YSXT | PLUR |
|---|---|---|
| Relative Strength Index (RSI) | 42.45 | 46.86 |
| Support Level | $1.37 | $3.01 |
| Resistance Level | $1.44 | $3.21 |
| Average True Range (ATR) | 0.08 | 0.15 |
| MACD | 0.04 | 0.03 |
| Stochastic Oscillator | 56.52 | 46.41 |
Price Performance
Historical ComparisonAbout YSXT YSX Tech. Co. Ltd Class A Ordinary Shares
YSX Tech Co Ltd provide business solutions to enterprise customers, mainly insurance companies and brokerages, in China. The company has three operating segments: Auto Insurance Aftermarket Value-added Services, Other Scenario-based Customized Services and Software Development and Information Technology Services. Key revenue is generated from Auto Insurance Aftermarket Value-added Services segment which include four types value added services: vehicle safety inspection and check services, vehicle driving risk screening services, designated driver and rescue services and vehicle maintenance and other value-added services.
About PLUR Pluri Inc.
Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.